People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

7.01CAD
25 Nov 2014
Price Change (% chg)

$-0.19 (-2.64%)
Prev Close
$7.20
Open
$7.20
Day's High
$7.20
Day's Low
$7.01
Volume
755
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks

Damiani, Carl 

Brief Biography

Mr. Carl Damiani is Chief Operating Officer, Vice President - Business Development of Transition Therapeutics Inc. Mr. Damiani is a key member of the Company's management team and is responsible for a broad range of activities, including licensing and intellectual property strategies. Prior to joining Transition, Mr. Damiani led multiple successful start-up businesses in the biotech and services industries.

Basic Compensation

Total Annual Compensation, CAD Long-Term Incentive Plans, CAD All Other, CAD Fiscal Year Total, CAD
199,228 -- -- 199,228

Options Compensation

  Quantity Market Value
Exercisable 63,083 335,861.00
Unexercisable 129,694 122,502.00
Exercised -- --
Name Fiscal Year Total

Tony Cruz

424,876

Nicole Rusaw

316,054

Carl Damiani

199,228

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of 29 Jun 2013
Search Stocks